Abstract. The immune response to Mycobacterium tuberculosis (Mtb) infection is the formation of multicellular lesions, or granolomas, in the lung of the individual. However, the structure of the granulomas and the spatial distribution of the immune cells within is not well understood.
Introduction
Tuberculosis (TB) is an aerosol-transmitted infectious disease that accounts for approximately 1.5 million deaths per year. It has been estimated that there were 8.4 million new cases of TB in 1999 [41] and that, currently, 1/3 of the world's population is infected with Mycobacterium tuberculosis (Mtb) [10] . However, infection rarely leads to active disease. For most people, the body's immune response is effective in either clearing or containing the pathogen, resulting in latent infection. This usually occurs anywhere from 2-5 years after initial infection [1, 4] immune response to Mtb is the development and maintenance of unique lesions, called granulomas, in the lung of infected individuals. Granulomas are multi-cellular spheroids, consisting of bacteria, macrophages and other immune cells. It may be that how these granulomas form and how well they function could be determinant in disease progression, i.e. latency or active disease. There is evidence that smaller solid granulomas (< 3mm in size) are formed in patients whose immune system is controlling the infection. Larger, caseous granulomas (> 5mm in size) are less likely to effectively contain bacterial growth and spread. Thus, granuloma size and structure may contribute to the outcome of infection [5, 7] . Reactivation of latent infection can occur if the immune system is compromised in some way, e.g. through infection with human immunodeficiency virus (HIV-1), aging, drug and alcohol abuse [9] .
In any infection, the first line of defense against a pathogen is the innate immune response. The initial site of Mtb infection is the alveoli of the lung, where it comes into contact with lung macrophages and dendritic cells. Macrophages respond to bacterial infections by the process of phagocytosis: the engulfment of bacteria. These macrophages are both uninfected and unactivated, meaning that they do not contain bacteria (uninfected) and are less efficient at phagocytosis than activated macrophages [6] . Activated macrophages become efficient at phagocytosis and bacterial killing due to the presence of T cells and cytokines [8, 24, 36] . Phagocytes are attracted to sites of infection via the release of chemokines by a variety of cell types. During Mycobacterium tuberculosis (Mtb) infection, epithelial cells, resident macrophages, T cells and bacteria each release chemokines that promote migration of immune system cells to the infection site. Similar processes also occur in tumors, wound healing and arthritis. It is speculated that if macrophages phagocytose and kill bacteria quickly, infection can conceivably be cleared [32, 38] . However, Mtb has evolved to resist killing by unactivated macrophages. In fact, it prefers to reproduce within macrophages [21] . The intracellular bacteria population of its host macrophage can become so large that the macrophage bursts and dies [38] . Therefore, a more forceful response is required and adaptive immunity develops. Infected macrophages release various chemokines (e.g. IL-8, MIP2, IP-10, MCP-1) that attract macrophages, neutrophils and T cells to sites of infection [13] . Additionally, macrophages produce cytokines (e.g. IL-12, TNF-α) that both up-and down-regulate adaptive immunity [9] .
In this paper we develop a model of the innate immune response to Mtb infection. We wish to capture migration of uninfected macrophages to the site of infection and their subsequent phagocytosis of bacteria. Macrophage movement to the site of infection occurs via both random motion and directed cell movement (chemotaxis) due to chemokines released by bacteria. For example, Sannoyima et al. [30] discovered that fMet-Leu-Phe is one of the proteins released by bacteria that is a known chemoattractant. Once in the lung, macrophages phagocytose bacteria. Infected macrophages are able to kill their intracellular bacteria. However, their killing capacity is much lower than that for macrophages activated via T cell and cytokine signals. In fact, chronically infected macrophages are known to be less effective at a variety of immune functions. For example, infected macrophages have diminished phagocytic potential, a decreased level of MHC-II presentation (which
